WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 80'277  79'360  78'411  77'435  76'454  66'132  56'226  38'668 
Births 1'325  1'355  1'376  1'389  1'392  1'239  1'839  1'736 
Surviving infants 1'309  1'337  1'357  1'369  1'371  1'204  1'758  1'593 
Pop. less than 5 years 6'823  6'899  6'900  6'860  6'773  6'409  9'354  6'850 
Pop. less than 15 years 19'005  18'755  18'453  18'148  17'871  23'107  25'512  16'831 
Female 15-49 years 23'665  23'594  23'492  23'371  23'220  17'596  12'224  8'487 

Number of reported cases

(Click for retrospective incidence data for Iran (Islamic Republic of))
Diphtheria
ChartChart
  10  28  13  190  150  18  373  139 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  82  615  99  189  332  11'874  5'341  31'130 
Mumps
ChartChart
  10'417 
Pertussis
ChartChart
  116  145  115  1'415  1'329  94  1'230  20'395 
Polio*
ChartChart
  15  80 
Rubella
ChartChart
  18  45  14  32  30  1'154 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  13  26 
Tetanus (total)**
ChartChart
  11  10  13  27  30  86 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Iran (Islamic Republic of))
Vaccine year result method % card seen                                                
BCG 1989  92  EPI     99*  99*  99*  99*  99*  99  95 
DTP1 1986  94  EPI     99  99  99  98  98  99* 
DTP3 1989  88  EPI     99  98  99  98  99  99*  91  32 
DTP4          99  98  98 
IPV1         
HepB_BD          95  96  97  99  96  99 
HepB3          99  98  99  99  98  99* 
Hib3          99  98 
JapEnc         
MCV1          99  99  99  98  98  99*  85  39 
MCV2          98  98  98  97  97  99* 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 1989  88  EPI     99  98  99  98  99  99*  90  38 
Rota1         
RotaC         
RCV1          99  99  99  98  98 
TT2plus          25  25  25  25  95  46  63 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Iran (Islamic Republic of))
BCG
ChartChart
  99  99  99  99  99  99  95 
DTP1
ChartChart
  99  99  99  98  99  99  97  57 
DTP3
ChartChart
  99  98  99  98  99  99  91  32 
HepB3
ChartChart
  99  98  99  99  98  99 
HepB_BD
ChartChart
  95  96  97  99  96  99 
Hib3
ChartChart
  99  98 
IPV1
 
MCV1
ChartChart
  99  99  99  98  98  99  85  39 
MCV2
ChartChart
  98  98  98  97  97  99 
PCV3
 
Pol3
ChartChart
  99  98  99  98  99  99  90  38 
RCV1
ChartChart
  99  99  99  98  98 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 426  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6, 18 months; 6 years; Yes
DTwP 18 months; 6 years; Yes
DTwPHibHepB 2, 4, 6 months Yes
HepB birth; Yes
HepB_Adult Yes Medical students and HCWs, High risk groups
HIB 2, 4, 6 months; Yes for cases who shoud not receive Pertussis vaccine
Influenza_Adult Yes Elderly, chronic illness, pregnant women, health care workers , Haj or other travellers
Influenza_Pediatric Yes and chronic illness
IPV 4 months; Yes only in high risk areas in 2016 ( due to vaccine shortage)
MenAC Yes military
MMR 12, 18 months; Yes
OPV birth; 2, 4, 6, 18 months; 6 years; Yes
Rubella Yes CBAW in pre-pregnancy visits
Td Yes repeated every 10 years - military and pregnant women
Varicella Yes Children with lymphatic and hematologic malignancies and their siblings
YF Yes Travellers to endemic countries

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2012-2016  2012-2016  2012-2016  2010-2014 
Nº of districts with microplans that include activities to raise immunization coverage number 10 

System performance

Total Nº districts in country number 426  425  422  411  405  392  360 
Nº districts with DTP3 coverage >=80% number 426  425  422  411  405  392  360 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 426  425  422  410  405  387  355 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  100  100  99  99 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.